NUP210 and primary biliary cholangitis: Anti-gp210 is a specific (>98%) anti-nuclear antibody targeting a transmembrane nuclear pore complex and can be diagnostic in PBC patients who do not have AMA (Courvalin and Worman, 1997; Haldar et al., 2021).